|
TMEM43 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.626032641866E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.76445533131664E-14 |
| Normal-vs-Stage2 |
2.806600E-01 |
| Normal-vs-Stage3 |
1.23309999988663E-08 |
| Normal-vs-Stage4 |
1.37060029992142E-10 |
| Stage1-vs-Stage2 |
2.122500E-03 |
| Stage1-vs-Stage3 |
2.315600E-01 |
| Stage1-vs-Stage4 |
8.420000E-02 |
| Stage2-vs-Stage3 |
2.616100E-02 |
| Stage2-vs-Stage4 |
9.6828999999965E-05 |
| Stage3-vs-Stage4 |
5.541300E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
2.317200E-03 |
| Normal-vs-Asian |
2.46070000042842E-07 |
| Caucasian-vs-AfricanAmerican |
7.851400E-01 |
| Caucasian-vs-Asian |
3.375800E-01 |
| AfricanAmerican-vs-Asian |
4.007400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.86129997262697E-09 |
| Normal-vs-Female |
1.63957736276643E-12 |
| Male-vs-Female |
9.579600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.1094237467878E-14 |
| Normal-vs-Age(41-60Yrs) |
3.42289530053108E-11 |
| Normal-vs-Age(61-80Yrs) |
5.245800E-04 |
| Normal-vs-Age(81-100Yrs) |
1.000030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.198400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.660360E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.502000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.455600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.151200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.772000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.647200E-01 |
| Classical-VS-Follicular |
1.62447832963153E-12 |
| Classical-VS-Other |
3.435200E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.64002145197628E-12 |
| Tall-VS-Other |
3.132200E-01 |
| Tall-VS-Normal |
1.66855418370915E-12 |
| Follicular-VS-Other |
9.719600E-03 |
| Follicular-VS-Normal |
4.209500E-02 |
| Other-VS-Normal |
1.306440E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.48480000000417E-05 |
| Normal-vs-N1 |
1.87490001302137E-09 |
| N0-vs-N1 |
2.445000E-03 |
|
|
